These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6351625)

  • 21. [Reaction of leukocyte migration inhibition in patients with uveal melanoblastoma].
    Nifontova TP
    Vopr Onkol; 1986; 32(4):57-61. PubMed ID: 3705529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infiltrating lymphocytes and antigen expression in uveal melanoma.
    Meecham WJ; Char DH; Kaleta-Michaels S
    Ophthalmic Res; 1992; 24(1):20-6. PubMed ID: 1608588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of HLA antigens in paraffin sections of uveal melanomas.
    Jager MJ; de Wolff-Rouendaal D; Breebaart AC; Ruiter DJ
    Doc Ophthalmol; 1986 Dec; 64(1):69-76. PubMed ID: 3556115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies.
    Komatsubara KM; Carvajal RD
    Curr Oncol Rep; 2017 Jul; 19(7):45. PubMed ID: 28508938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A preliminary report on monoclonal antibodies against human uveal melanoma.
    Kalafut F; Kusenda J; Novotná L; Cernák A
    Neoplasma; 1987; 34(6):693-701. PubMed ID: 3431609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunologic aspects in the diagnosis of uveal melanoma].
    Omulecki W
    Klin Oczna; 1986 May; 88(5):175-7. PubMed ID: 3540439
    [No Abstract]   [Full Text] [Related]  

  • 27. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma.
    Errington JA; Conway RM; Walsh-Conway N; Browning J; Freyer C; Cebon J; Madigan MC
    Br J Ophthalmol; 2012 Mar; 96(3):451-8. PubMed ID: 22190731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunophenotypic markers to differentiate between benign and malignant melanocytic lesions.
    Keijser S; Missotten GS; Bonfrer JM; de Wolff-Rouendaal D; Jager MJ; de Keizer RJ
    Br J Ophthalmol; 2006 Feb; 90(2):213-7. PubMed ID: 16424536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Membrane-bound regulators of complement activation in uveal melanomas. CD46, CD55, and CD59 in uveal melanomas.
    Goslings WR; Blom DJ; de Waard-Siebinga I; van Beelen E; Claas FH; Jager MJ; Gorter A
    Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1884-91. PubMed ID: 8759358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melanoma-associated antigens: prospects for clinical use.
    Lejeune FJ; Libert A
    Eur J Cancer Clin Oncol; 1985 Dec; 21(12):1433-8. PubMed ID: 3830723
    [No Abstract]   [Full Text] [Related]  

  • 31. Metastatic uveal melanoma: an ocular melanoma associated antigen in the serum of patients with metastatic disease.
    Donoso LA; Felberg NT; Edelberg K; Borlinghaus P; Herlyn M
    J Immunoassay; 1986; 7(4):273-83. PubMed ID: 3805289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study of the intracytoplasmatic antigens of malignant melanoma cells. Preliminary report].
    De Moragas J; Anguera A; Viñas J
    Actas Dermosifiliogr; 1971; 62(9):429-32. PubMed ID: 4949557
    [No Abstract]   [Full Text] [Related]  

  • 33. Melanocytoma-like melanoma may be the missing link between benign and malignant uveal melanocytic lesions in humans and dogs: a comparative study.
    Zoroquiain P; Mayo-Goldberg E; Alghamdi S; Alhumaid S; Perlmann E; Barros P; Mayo N; Burnier MN
    Melanoma Res; 2016 Dec; 26(6):565-571. PubMed ID: 27571324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas.
    Chi DD; Merchant RE; Rand R; Conrad AJ; Garrison D; Turner R; Morton DL; Hoon DS
    Am J Pathol; 1997 Jun; 150(6):2143-52. PubMed ID: 9176405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anthropometry in the immunotherapy of cutaneous and ocular melanomas.
    Săftescu S; Munteanu M; Popovici D; Dragomir R; Dărăbuș MD; Negru AG; Negru ȘM
    Rom J Ophthalmol; 2020; 64(2):190-194. PubMed ID: 32685786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spontaneous cellular and humoral tumor antigen responses in patients with uveal melanoma.
    Triozzi PL; Aldrich W; Crabb JW; Singh AD
    Melanoma Res; 2015 Dec; 25(6):510-8. PubMed ID: 26397048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B-lymphocytes from melanoma patients and normal individuals react with melanoma cells but also with irrelevant antigens.
    Damato BE; Campbell AM; McGuire BJ; Lee WR; Foulds WS
    Br J Cancer; 1988 Aug; 58(2):182-5. PubMed ID: 3262365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of monoclonal antibodies in detection of melanoma-associated antigens in intact human tumors.
    Thompson JJ; Herlyn MF; Elder DE; Clark WH; Steplewski Z; Koprowski H
    Am J Pathol; 1982 Jun; 107(3):357-61. PubMed ID: 6177248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical study of melanocytic differentiation antigens in cutaneous malignant melanoma. A comparison of six commercial antibodies and one non-commercial antibody in nodular melanoma, superficially spreading melanoma and lentigo maligna melanoma.
    Kocan P; Jurkovic I; Böör A; Dudríková K; Krajcár R; Benický M; Kromydaki A
    Cesk Patol; 2004 Apr; 40(2):50-6. PubMed ID: 15233017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The characterization of tumour-associated membrane-bound antigens and their implementation in the treatment of malignant melanoma (author's transl)].
    Kokoschka EM
    Wien Klin Wochenschr Suppl; 1979; 97():3-32. PubMed ID: 106559
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.